Histogen to Present at the Canaccord Genuity 40th Annual Growth Conference
Rhea-AI Summary
Histogen Inc. (NASDAQ: HSTO) announced that CEO Richard W. Pascoe will present at the Canaccord Genuity 40th Annual Growth Conference on August 12, 2020, at 1:30 p.m. Eastern Time. The virtual event will discuss Histogen's focus on developing first-in-class restorative therapeutics aimed at enhancing natural body repair processes. Interested participants can access the live webcast through a provided link, and a replay will be available for 90 days on the company’s website. Histogen specializes in therapeutic solutions for hair growth, dermal rejuvenation, and joint cartilage regeneration.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, HSTO gained 3.85%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen, will present at the Canaccord Genuity 40th Annual Growth Conference. The virtual presentation is scheduled for Wednesday, August 12, 2020 at 1:30 p.m. Eastern Time.
Presentation Details
Date: Wednesday August 12, 2020
Time: 1:30 p.m. Eastern Time (10:30 a.m. Pacific Time)
Live Webcast Link: https://wsw.com/webcast/canaccord42/hsto
For those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on www.histogen.com.
About Histogen Inc.
Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair. For more information, please visit www.histogen.com.
CONTACT:
Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com
FAQ
When is Richard W. Pascoe presenting for Histogen at the Canaccord Genuity conference?
Where can I watch the Histogen presentation live?
What is Histogen focused on developing?
How can I access the replay of the Histogen conference presentation?
What types of therapies does Histogen work on?
